|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Whether you are a healthcare professional, a patient or simply someone looking to know more about the complete solutions offered by Cordis, let us show you how our distinctive approach to working in partnership with you results in innovative interventional products and services to help support sustained patient outcomes.
SCAI Releases Recommended Quality Core Curriculum for Interventional Cardiology Fellowship Programs
Quality assessment and continuous quality improvement are essential to the practice of interventional cardiology, and interventional fellowship training programs should include specific education and experience in these areas to ensure new interventional cardiologists are prepared to make quality an integral part of their future practice, according to new recommendations for quality core curriculum in adult and pediatric interventional fellowship programs released during SCAI 2015 Scientific Sessions in San Diego.
"As interventional cardiology evolves, procedures are becoming more complex and diverse. Quality assessment and quality improvement are essential to ensuring that the right patient receives the right procedure at the right time and in the right way," said Joaquin E. Cigarroa, MD, FSCAI, the senior author of the paper. "While cardiovascular professional societies have actively developed new clinical guidelines, expert consensus statements and appropriate use criteria, this is the first consensus statement to define the best framework for teaching quality to new interventional cardiology fellows." Find out more.
Related: Download this new SCAI expert consensus document.
CMS Opens National Coverage Decision Making Process on Left Atrial Appendage Closure Procedures
Medicare officials are asking for public comments on Boston Scientific's request for a national decision on coverage of left atrial appendage closure procedures. Submit your comments by June 20. SCAI will comment as well as work with other societies on clinical competency documents and clinical data registry options. SCAI's impression is that recommendations of the profession will play a significant role in Medicare's policies on left atrial appendage occlusion.
Five CHI Health Facilities in Nebraska, Iowa Recognized for High-Quality Care by ACE
Accreditation for Cardiovascular Excellence
This month, Accreditation for Cardiovascular Excellence (ACE) recognized five cardiac catheterization labs in Nebraska and Iowa for meeting, or exceeding, nationally accepted best-practices in invasive and interventional cardiology care. The cath labs are part of the Catholic Health Initiatives (CHI) Health, which operates hospitals and other health care facilities in 18 states and has several more of its cardiac cath labs on track to achieve this distinction from ACE.
The cath labs recognized this month include CHI Health Bergan Mercy, CHI Health Immanuel and CHI Health Lakeside, all in Omaha; CHI Health Midlands in Papillion, Nebraska; and CHI Health Mercy in Council Bluffs, Iowa.
For more information about ACE's quality review and accreditation services, visit www.cvexcel.org.
Resource Alert: American Hospital Association Publishes AUC for PCI Toolkit
Last week, the American Hospital Association (AHA) distributed a new compendium of tools focused on the appropriate use of elective PCI. The AHA toolkit features a variety of resources developed by SCAI as well as the American College of Cardiology and American Heart Association. The AHA organized the toolkit by audience: Hospital/Health Systems, Clinicians and Patients. Each grouping includes links to SCAI tools, such as SCAI-Quality Improvement Toolkit, SCAI's AUC and Risk Calculator apps, practice guidelines and expert consensus documents and SCAI's public information website, SecondsCount.org.
The AHA has previously published toolkits focused on patient blood management, antimicrobial stewardship and ambulatory care sensitive conditions.
Access the AHA's Elective PCI toolkit.
Miss SCAI 2015? Catch Up With All the Sessions With SCAI 2015 On Demand
Find out why SCAI 2015 created so much buzz with SCAI 2015 On Demand.
SCAI 2015 On Demand allows you to catch up on all that you missed at Interventional Cardiology's Annual Meeting, including the full-day Cath Lab Leadership Boot Camp, our Coronary, Congenital, Peripheral and Structural Tracks and our Saturday programming on heart failure, new technologies in the cath lab and six hours of content specific to the cath lab team.
Atrial Septal Closure Device Explant May Resolve Nickel Allergy Symptoms
Patients with nickel allergy and severe refractory symptoms after implantation with an atrial septal closure device experienced complete resolution of symptoms after device explantation, according to a report presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions. Divya Ratan Verma, MD, MS, from University of Utah Hospitals and Clinics, said a small number of patients with cardiac pathology who are implanted with biomedical devices may experience allergic reactions to nickel as the device corrodes, releasing nickel particles that trigger immune response.
Heart 'Could Be Regenerated by Lymphatic System' After Heart Attacks
Medical News Today
Researchers have discovered a new way to limit the damage caused to the heart by a heart attack — by regenerating the heart through the growth of lymphatic vessels. The team from the University of Oxford in the U.K. identified that stimulating the growth of lymphatic vessels in mice using a protein called VEGF-C improved the healing process and the ejection fraction in VEGF-C treated mice.
Transcatheter Pulmonary Valve Provides Less Invasive Option for Some Children With Congenital Heart Disease
Device-related adverse events were rare among children implanted with a transcatheter pulmonary valve, according to new data from the FDA Manufacturer and User Facility Device Experience database. The Melody Transcatheter Pulmonary Valve (Medtronic) was approved by the Food and Drug Administration in 2010 under a Humanitarian Device Exemption (HDE) for the treatment of patients with congenital heart disease and failing heart valves. According to Gregory Fleming, MD, MS, from Duke University Medical Center, "the valve has changed the way that we manage patients with right ventricular to pulmonary artery conduit dysfunction."
Trials Explore the Potential of Biodegradable-Polymer Stents
Two trials conducted in all-comers populations provide new information on how DES equipped with a biodegradable polymer might benefit patients. The data were presented on May 19, 2015, at EuroPCR. Final three-year results of NEXT showed that newer technology offers outcomes comparable to those of a permanent-polymer DES but, on the other hand, does not seem to hold any long-term advantage.
Cilostazol as Bridging Therapy Warrants Further Research
The most quoted research publications are those that address clinically frustrating scenarios for which we have no answer. Charles Laham, MD, FSCAI, and colleagues attempted to answer such a question with the OUTSIDE START study: That is, what can we do for patients who require interruption to dual antiplatelet therapy after PCI due to urgent and unavoidable surgeries?
Where There's Vapor ... Electronic Cigarette Use Causes Concern Among Doctors
It's official. Cigarette smoking isn't as cool as it used to be, and kids aren't taking up that habit as they once did.
That would be good news, except for what has replaced traditional cigarettes: a combination of new technology and the old addictive substance of nicotine.
OPERA HF: Moderate, Severe Depression May Independently Increase Mortality Risk in Heart-Failure Patients
Severe depression and heart failure may be an even deadlier mix than previously thought, suggests new research presented at the Heart Failure Congress 2015 of the European Society of Cardiology Heart Failure Association.
Early analysis of 154 participants in the ongoing Observational Study to Predict Readmission for Heart Failure Patients (OPERA-HF) trial showed that, within a year after hospital discharge, those with moderate to severe depression scores were more than five times more likely to die than those with lower scores — and the risk remained this high even after controlling for demographics, health factors and comorbidities.
PARTNER II: Manageable Risk of Paravalvular Leak With Sapien 3 in Lower-Risk Patients
In intermediate-risk patients with aortic stenosis, TAVR with the Sapien 3 device results in a low risk of paravalvular regurgitation with nominal oversizing, according to a study presented May 20, 2015, at EuroPCR. "Importantly, the degree of oversizing needed to avoid greater than moderate paravalvular leak appears less than for previous Sapien generations, emphasizing the need for a device-specific CT-sizing algorithm," said presenter Philipp Blanke, MD, of St. Paul's Hospital.
Benefit-Risk Assessment Tilts Toward Low-Dose Aspirin After PCI
An analysis of TRANSLATE-ACS data supports current guideline recommendations to prescribe low-dose aspirin to patients who underwent PCI and received dual antiplatelet therapy. The study was published online May 20 in Circulation. TRANSLATE-ACS was a prospective, observational study that enrolled STEMI and non-STEMI patients who received PCI between 2010 and 2012 and were treated with ADP receptor inhibitors.
Can Allopurinol Reduce Heart Attack Risk?
In a case-control study, Grimaldi-Bensouda and colleagues used a large French registry to evaluate the relationship between allopurinol use and first myocardial infarction. Patients from the Pharmacoepidemiological General Research on MI registry were included if they had a history of an initial nonfatal MI and were matched with controls from general practice settings who did not have a history of MI.
10 Questions: Theodore A. Bass, MD
Theodore A. Bass, MD, MSCAI, is chief of cardiology and medical director of the Cardiovascular Center at the University of Florida Health Science Center in Jacksonville. He also serves as a professor and program director for the interventional cardiology fellowship there.
Dr. Bass is a past president of SCAI. At SCAI 2015, he answered 10 questions about his career and his observations about healthcare.
For a complete list of job postings, click here
To post your resume, click here
||SCAI-QIT Webinar: Documentation of PCI Procedures
||SCAI TAVR Session @ SOLACI
SCAI Fellows Course at LWSIC
||SCAI China Fellows Course
||SCAI CPVI - Complex Peripheral Vascular Interventions
SCAI at Great Wall International Congress of Cardiology
||SCAI 2015 Fall Fellows Courses
|May 4-7, 2016
||SCAI 2016 Scientific Sessions
The news summaries appearing in SCAI This Week are based on original information from news organizations and are produced by Multibriefs, an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI This Week constitute the official opinion of SCAI.
The SCAI This Week news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI This Week may be directed to Multibriefs at email@example.com.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063